Estimating the Ovarian Cancer CA-125 Preclinical Detectable Phase, In-Vivo Tumour Doubling Time, and Window for Detection in Early Stage: An Exploratory Analysis of UKCTOCS
dc.contributor.author | Bedia, JS | |
dc.contributor.author | Jacobs, IJ | |
dc.contributor.author | Ryan, A | |
dc.contributor.author | Gentry-Maharaj, A | |
dc.contributor.author | Burnell, M | |
dc.contributor.author | Manchanda, R | |
dc.contributor.author | Kalsi, JK | |
dc.contributor.author | Dawnay, A | |
dc.contributor.author | Fallowfield, L | |
dc.contributor.author | McGuire, A | |
dc.contributor.author | Campbell, S | |
dc.contributor.author | Parmar, MKB | |
dc.contributor.author | Menon, U | |
dc.contributor.author | Skates, SJ | |
dc.date.accessioned | 2024-05-30T11:34:21Z | |
dc.date.available | 2024-05-30T11:34:21Z | |
dc.date.issued | 2024 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/97103 | |
dc.publisher | Elsevier BV | en_US |
dc.relation.ispartof | The Lancet | |
dc.title | Estimating the Ovarian Cancer CA-125 Preclinical Detectable Phase, In-Vivo Tumour Doubling Time, and Window for Detection in Early Stage: An Exploratory Analysis of UKCTOCS | en_US |
dc.identifier.doi | 10.2139/ssrn.4834024 | |
pubs.notes | Not known | en_US |
pubs.publisher-url | http://dx.doi.org/10.2139/ssrn.4834024 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Cancer Prevention [1181]